The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Amyloid PET imaging in patients with mild cognitive impairment: A 2-year follow-up study
Abstract
BACKGROUND: Patients with amnestic mild cognitive impairment (MCI) have greater risk of conversion to Alzheimer disease (AD). Increased brain amyloid burden in AD and MCI has been demonstrated with PET using [(11)C] Pittsburgh compound B (PiB) as a tracer. OBJECTIVE: To evaluate change in β-amyloid deposition in with MCI during 2-year follow-up. METHODS: Patients with MCI and controls were studied with [(11)C] PiB PET, MRI, and neuropsychometry at baseline and these investigations were repeated in patients with MCI after follow-up. RESULTS: Those patients with MCI converting to AD during follow-up had greater [(11)C] PiB retention in the posterior cingulate (p=0.020), in the lateral frontal cortex (p=0.006), in the temporal cortex (p=0.022), in the putamen (p=0.041), and in the caudate nucleus (p=0.025) as compared to nonconverters. In converters, there was no significant change in [(11)C] PiB uptake, whereas an increase was seen as compared to baseline in nonconverters in the anterior and posterior cingulate, temporal and parietal cortices, and putamen. Hippocampal atrophy was greater in converters at baseline than in nonconverters, but increased significantly in both groups during follow-up. CONCLUSIONS: Hippocampal atrophy and amyloid deposition seem to dissociate during the evolution of MCI, the atrophy increasing clearly and [(11)C] PiB retention changing modestly when conversion to AD occurs. Longer follow-up is needed to determine whether nonconverters would convert to AD later, which would suggest accelerated [(11)C] PiB retention preceding clinical conversion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“indicating a fundamental participation of microglia in the development and progression of AD.”
From Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation (2019) · cites this paper as [151]
In the citing paper
“PET imaging studies have shown that subjects with high amounts of amyloid-β, but no dementia, had decreased microglia activation [151–153]”
From Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation (2019) · cites this paper as [151]
Citations
Cites
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Scheltens, P., Leys, D., Barkhof, F., Huglo, D. G., Weinstein, H. C., Vermersch, P., Kuiper, M. A., Steinling, M., Wolters, E. C., & Valk, J. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.10.967 · Cited by 1,816
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404
Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099
[ 11 C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
Mintun, M. A., LaRossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., Klunk, W. E., Mathis, C. A., DeKosky, S. T., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000228230.26044.a4 · Cited by 1,036
Jack, C. R., Lowe, V. J., Senjem, M. L., Weigand, S. D., Kemp, B. J., Shiung, M. M., Knopman, D. S., Boeve, B. F., Klunk, W. E., Mathis, C. A., et al. (2008) · Brain · doi:10.1093/brain/awm336 · Cited by 958
Pike, K. E., Savage, G., Villemagne, V. L., Ng, S., Moss, S. A., Maruff, P., Mathis, C. A., Klunk, W. E., Masters, C. L., & Rowe, C. C. (2007) · Brain · doi:10.1093/brain/awm238 · Cited by 789
Reiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900345106 · Cited by 785
PET imaging of amyloid deposition in patients with mild cognitive impairment
Forsberg, A., Engler, H., Almkvist, O., Blomquist, G., Hagman, G., Wall, A. E., Ringheim, A., Långström, B., & Nordberg, A. K. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.029 · Cited by 725
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
Engler, H., Forsberg, A., Almkvist, O., Blomquist, G., Larsson, E., Savitcheva, I., Wall, A. E., Ringheim, A., Långström, B., & Nordberg, A. K. (2006) · Brain · doi:10.1093/brain/awl178 · Cited by 614
Cited by
Sorted by citations
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
Lima Giacobbo, B., Doorduin, J., Klein, H. C., Dierckx, R. A. J. O., Bromberg, E., & de Vries, E. F. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1283-6 · Cited by 750
Rathore, S., Habes, M., Iftikhar, M. A., Shacklett, A., & Davatzikos, C. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.03.057 · Cited by 622
AD dementia risk in late MCI, in early MCI, and in subjective memory impairment.
Jessen, F., Wolfsgruber, S., Wiese, B., Bickel, H., Mösch, E., Kaduszkiewicz, H., Pentzek, M., Riedel‐Heller, S. G., Luck, T., Fuchs, A., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.09.017 · Cited by 511
Disrupted Functional Brain Connectome in Individuals at Risk for Alzheimer's Disease
Wang, J., Zuo, X., Dai, Z., Xia, M., Zhao, Z., Zhao, X., Jia, J., Han, Y., & He, Y. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.026 · Cited by 432
Chételat, G., Joie, R. L., Villain, N., Perrotin, A., Sayette, V. D. L., Eustache, F., & Vandenberghe, R. R. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.02.006 · Cited by 363
Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia
Ewers, M., Sperling, R. A., Klunk, W. E., Weiner, M. W., & Hampel, H. J. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.05.005 · Cited by 360
van Oostveen, W. M., & de Lange, E. C. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042110 · Cited by 297
Villain, N., Chételat, G., Grassiot, B., Bourgeat, P., Jones, G., Ellis, K. A., Ames, D., Martins, R. N., Eustache, F., Salvado, O., et al. (2012) · Brain · doi:10.1093/brain/aws125 · Cited by 255
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline
Doraiswamy, P. M., Sperling, R. A., Coleman, R. E., Johnson, K. A., Reiman, E. M., Davis, M. D., Grundman, M., Sabbagh, M. N., Sadowsky, C., Fleisher, A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182661f74 · Cited by 235
Biomarkers for the Early Detection and Progression of Alzheimer's Disease
Counts, S. E., Ikonomovic, M. D., Mercado, N., Vega, I. E., & Mufson, E. J. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0481-z · Cited by 224
Rowe, C. C., Bourgeat, P., Ellis, K. A., Brown, B., Lim, Y. Y., Mulligan, R., Jones, G., Maruff, P., Woodward, M., Price, R., et al. (2013) · Annals of Neurology · doi:10.1002/ana.24040 · Cited by 222
Khazaee, A., Ebrahimzadeh, A., & Abbas Babajani-feremi, A. (2015) · Brain Imaging and Behavior · doi:10.1007/s11682-015-9448-7 · Cited by 215
Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play
Jack, C. R. (2012) · Radiology · doi:10.1148/radiol.12110433 · Cited by 211
Smailagic, N., Vacante, M., Hyde, C., Martin, S., Ukoumunne, O. C., & Sachpekidis, C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010632.pub2 · Cited by 235
Early detection of Alzheimer's disease using PiB and FDG PET
Cohen, A. D., & Klunk, W. E. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.001 · Cited by 216
Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study
AV45-A11 Study Group, Doraiswamy, P. M., Sperling, R. A., Johnson, K., Reiman, E. M., Wong, T. Z., Sabbagh, M. N., Sadowsky, C. H., Fleisher, A. S., Carpenter, A., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.9 · Cited by 195
Impact of molecular imaging on the diagnostic process in a memory clinic
Ossenkoppele, R., Prins, N. D., Pijnenburg, Y. A. L., Lemstra, A. W., van der Flier, W. M., Adriaanse, S. F., Windhorst, A. D., Handels, R. L. H., Wolfs, C. A. G., Aalten, P., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.07.003 · Cited by 194
Plasma microRNA biomarkers for detection of mild cognitive impairment
Sheinerman, K. S., Tsivinsky, V. G., Crawford, F., Mullan, M. J., Abdullah, L., & Umansky, S. R. (2012) · Aging · doi:10.18632/aging.100486 · Cited by 188
Morris, J. C. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.3152 · Cited by 180
Development of Positron Emission Tomography β-Amyloid Plaque Imaging Agents
Mathis, C. A., Mason, N. S., Lopresti, B. J., & Klunk, W. E. (2012) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2012.07.001 · Cited by 181
Synaptic Change in the Posterior Cingulate Gyrus in the Progression of Alzheimer's Disease
Scheff, S. W., PRICE, D. A., Ansari, M. A., Roberts, K. N., Schmitt, F. A., Ikonomović, M. D., & Mufson, E. J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141518 · Cited by 169
Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET
Ossenkoppele, R., Tolboom, N., Foster‐Dingley, J. C., Adriaanse, S. F., Boellaard, R., Yaqub, M. M., Windhorst, A. D., Barkhof, F., Lammertsma, A. A., Scheltens, P., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2102-3 · Cited by 164
The diagnostic value of FDG and amyloid PET in Alzheimer’s disease—A systematic review
Rice, L., & Bisdas, S. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2017.07.014 · Cited by 156
The Development, Past Achievements, and Future Directions of Brain PET
Jones, T., & Rabiner, E. A. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.20 · Cited by 145
Hampel, H. J., Lista, S., & Khachaturian, Z. S. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.2116 · Cited by 142
Cerebral amyloid PET imaging in Alzheimer’s disease
Jack, C. R., Barrio, J. R., & Kepe, V. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1185-7 · Cited by 137
Zhang, S., Han, D., Tan, X., Feng, J., Guo, Y., & Ding, Y. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02845.x · Cited by 123
Identifying incipient dementia individuals using machine learning and amyloid imaging
Mathotaarachchi, S., Pascoal, T. A., Shin, M., Benedet, A. L., Kang, M. S., Beaudry, T., Fonov, V. S., Gauthier, S., & Rosa-Neto, P. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.06.027 · Cited by 118
In vivo characterization of the early states of the amyloid-beta network
Sepulcre, J., Sabuncu, M. R., Becker, A., Sperling, R., & Johnson, K. A. (2013) · Brain · doi:10.1093/brain/awt146 · Cited by 117
Diniz, B. S., Sibille, E., Ding, Y., Tseng, G., Aizenstein, H. J., Lotrich, F., Becker, J. T., Lopez, O. L., Lotze, M. T., Klunk, W. E., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.76 · Cited by 116
Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease
Teipel, S. J., Heinsen, H., Amaro, E., Grinberg, L. T., Krause, B. J., & Grothe, M. J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.029 · Cited by 116
Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease
Cohen, A. D., Landau, S. M., Snitz, B. E., Klunk, W. E., Blennow, K., & Zetterberg, H. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.12.004 · Cited by 112
O’Dell, R. S., Mecca, A. P., Chen, M.-K., Naganawa, M., Toyonaga, T., Lu, Y., Godek, T. A., Harris, J. E., Bartlett, H. H., Banks, E. R., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00742-y · Cited by 107
Ferreira, L. K., & Busatto, G. F. (2011) · Clinics · doi:10.1590/s1807-59322011001300003 · Cited by 102
Synergistic interaction between amyloid and tau predicts the progression to dementia
Pascoal, T. A., Mathotaarachchi, S., Shin, M., Benedet, A. L., Mohades, S., Wang, S., Beaudry, T., Kang, M. S., Soucy, J., Labbe, A., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.11.005 · Cited by 101
Using Pittsburgh Compound B for In Vivo PET Imaging of Fibrillar Amyloid-Beta
Cohen, A. D., Rabinovici, G. D., Mathis, C. A., Jagust, W. J., Klunk, W. E., & Ikonomović, M. D. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00002-7 · Cited by 103
Dementia in Patients Hospitalized with Stroke: Rates, Time Course, and Clinico-Pathologic Factors
Pendlebury, S. T. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00837.x · Cited by 102
Biomarkers in Neurodegenerative Diseases
Jeromin, A., & Bowser, R. (2017) · Advances in Neurobiology · doi:10.1007/978-3-319-57193-5_20 · Cited by 92
Wolk, D. A., Sadowsky, C., Safirstein, B., Rinne, J. O., Duara, R., Perry, R. J., Agronin, M., Gamez, J., Shi, J., Ivanoiu, A., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0894 · Cited by 89
Self-citationRinne, J. O., Wong, D. F., Wolk, D. A., Leinonen, V., Arnold, S. E., Buckley, C. J., Smith, A. P. L., McLain, R. W., Sherwin, P. F., Farrar, G., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1051-z · Cited by 84
Self-citationRallabandi, V. P. S., & Seetharaman, K. (2022) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2022.104312 · Cited by 82
Biomarkers in Alzheimer's disease with a special emphasis on event-related oscillatory responses
Yener, G., & Başar, E. (2013) · Supplements to Clinical neurophysiology · doi:10.1016/b978-0-7020-5307-8.00020-x · Cited by 84
Potential Clinical Applications of PET/MR Imaging in Neurodegenerative Diseases
Drzezga, A. E., Barthel, H., Minoshima, S., & Sabri, O. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.129254 · Cited by 83
Aβ and cognitive change: Examining the preclinical and prodromal stages of Alzheimer's disease
Lim, Y. Y., Maruff, P. T., Pietrzak, R. H., Ellis, K. A., Darby, D., Ames, D. J., Harrington, K., Martins, R. N., Masters, C. L., Szoeke, C. E. I., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.11.005 · Cited by 84
Chiotis, K., Saint‐Aubert, L., Boccardi, M., Gietl, A. F., Picco, A., Varrone, A., Garibotto, V., Herholz, K., Nobili, F. M., Nordberg, A. K., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.07.012 · Cited by 75
Schreiber, S., Landau, S. M., Fero, A., Schreiber, F., & Jagust, W. J. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1633 · Cited by 79
Ma, Y., Zhang, S., Li, J., Zheng, D., Guo, Y., Feng, J., & Ren, W.-D. (2014) · Medicine · doi:10.1097/md.0000000000000150 · Cited by 73
Koychev, I. G., on behalf of the Deep and Frequent Phenotyping study team (http://www.dementiastudy.co.uk/), Gunn, R. N., Firouzian, A., Lawson, J., Zamboni, G., Ridha, B. H., Sahakian, B. J., Rowe, J. B., Thomas, A. J., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170129 · Cited by 67
Zhang, S., Smailagic, N., Hyde, C., Noel-Storr, A. H., Takwoingi, Y., McShane, R., & Feng, J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010386.pub2 · Cited by 66
Clinical and research diagnostic criteria for Alzheimer's disease
Sarazin, M., de Souza, L. C., Lehéricy, S., & Dubois, B. (2012) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2011.11.004 · Cited by 64
Cilento, E. M., Jin, L., Stewart, T., Shi, M., Sheng, L., & Zhang, J. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14635 · Cited by 60
Heurling, K., Leuzy, A., Zimmer, E. R., Lubberink, M., & Nordberg, A. K. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3208-1 · Cited by 59
Han, S. D., Arfanakis, K., Fleischman, D. A., Leurgans, S. E., Tuminello, E. R., Edmonds, E. C., & Bennett, D. A. (2011) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617711001299 · Cited by 59
A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis
Perani, D., Schillaci, O., Padovani, A., Nobili, F. M., Iaccarino, L., Pasquale, D. R., Frisoni, G. B., & Caltagirone, C. (2014) · BioMed Research International · doi:10.1155/2014/785039 · Cited by 61
Choo, I. H., Ni, R., Schöll, M., Wall, A. E., Almkvist, O., & Nordberg, A. K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121489 · Cited by 59
Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old
López, O. L., Klunk, W. E., Mathis, C. A., Coleman, R., Price, J. C., Becker, J. T., Aizenstein, H. J., Snitz, B. E., Cohen, A. D., Ikonomović, M. D., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000977 · Cited by 57
Stable Size Distribution of Amyloid Plaques Over the Course of Alzheimer Disease
Serrano‐Pozo, A., Mielke, M. L., Muzitansky, A., Gómez‐Isla, T., Growdon, J. H., Bacskai, B. J., Betensky, R. A., Frosch, M. P., & Hyman, B. T. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825e77de · Cited by 57
[11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment
Brück, A., Virta, J. R., Koivunen, J., Koikkalainen, J. R., Scheinin, N. M., Helenius, H. Y. M., Någren, K., Helin, S., Parkkola, R. K., Viitanen, M. H., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2478-8 · Cited by 55
Self-citationPET Imaging for Early Detection of Alzheimer’s Disease
Bao, W., Jia, H., Finnema, S. J., Cai, Z., Carson, R. E., & Huang, Y. H. (2017) · PET Clinics · doi:10.1016/j.cpet.2017.03.001 · Cited by 54
Dissociation between Brain Amyloid Deposition and Metabolism in Early Mild Cognitive Impairment
Wu, L., Rowley, J., Mohades, S., Leuzy, A., Dauar, M. T., Shin, M., Fonov, V., Jia, J., Gauthier, S. G., Rosa‐Neto, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047905 · Cited by 55
Noradrenaline in the aging brain: Promoting cognitive reserve or accelerating Alzheimer's disease?
Mather, M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.05.013 · Cited by 57
How technology is reshaping cognitive assessment: Lessons from the Framingham Heart Study.
Au, R., Piers, R. J., & Devine, S. (2017) · Neuropsychology · doi:10.1037/neu0000411 · Cited by 53
Neuroimaging in the early diagnosis of neurodegenerative disease
Stoessl, A. J. (2012) · Translational Neurodegeneration · doi:10.1186/2047-9158-1-5 · Cited by 52
Leinonen, V., Rinne, J. O., Virtanen, K. A., Eskola, O., Rummukainen, J., Huttunen, J., zu Fraunberg, M. V. U., Nerg, O., Koivisto, A. M., Rinne, J., et al. (2013) · European Journal of Neurology · doi:10.1111/ene.12102 · Cited by 43
Self-citationDisclosure of amyloid imaging results to research participants: Has the time come?
Lingler, J. H., & Klunk, W. E. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.09.014 · Cited by 44
Ye, B. S., Kim, Y. J., Kim, Y. J., Jung, N., Lee, J. S., Lee, J., Jang, Y. K., Yang, J., Lee, J. M., Vogel, J. W., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23676-w · Cited by 41
Evaluation of neuroprotective effect of glucagon‐like peptide 1 analogs using neuroimaging
Femminella, G. D., & Edison, P. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.12.012 · Cited by 43
Predicting amyloid positivity in patients with mild cognitive impairment using a radiomics approach
Kim, J. P., Kim, J., Jang, H., Kim, J., Kang, S. H., Kim, J. S., Lee, J. M., Na, D. L., Kim, H. J., Seo, S. W., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-86114-4 · Cited by 42
Five-year follow-up of 11C-PIB uptake in Alzheimer’s disease and MCI
Kemppainen, N. M., Scheinin, N. M., Koivunen, J., Johansson, J. J., Toivonen, J., Någren, K., Rokka, J., Karrasch, M., Parkkola, R. K., & Rinne, J. O. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2562-0 · Cited by 40
Self-citationGhosh, S., Libon, D. J., & Lippa, C. F. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513517040 · Cited by 40
Hanon, O., Vidal, J., Lehmann, S., Bombois, S., Allinquant, B., Rose, C., Tréluyer, J., Abdoul, H., Gelé, P., Delmaire, C., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12613 · Cited by 38
The neurobiology of Alzheimer disease defined by neuroimaging
Masdeu, J. C., Kreisl, W. C., & Berman, K. F. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283557b36 · Cited by 39
Defrancesco, M., Egger, K. E., Marksteiner, J., Esterhammer, R., Hinterhuber, H., Deisenhammer, E., & Schocke, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106062 · Cited by 38
Tentolouris-Piperas, V., Ryan, N. S., Thomas, D. L., & Kinnunen, K. M. (2016) · Brain Research · doi:10.1016/j.brainres.2016.11.011 · Cited by 38
Guo, T., Dukart, J., Brendel, M., Rominger, A., Grimmer, T., Yakushev, I. Y., & Initiative, A. D. N. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.05.013 · Cited by 37
Lim, Y. Y., Ellis, K. A., Harrington, K., Pietrzak, R. H., Gale, J., Ames, D. J., Bush, A. I., Darby, D., Martins, R. N., Masters, C. L., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121771 · Cited by 38
The prognostic value of amyloid imaging
Gelosa, G., & Brooks, D. J. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2108-x · Cited by 35
Should We Disclose Amyloid Imaging Results to Cognitively Normal Individuals?
Grill, J. D., Johnson, D. K., & Burns, J. M. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.12.75 · Cited by 36
Biomarkers in Alzheimer’s Disease
Riverol, M., & López, O. L. (2011) · Frontiers in Neurology · doi:10.3389/fneur.2011.00046 · Cited by 33
Zwan, M. D., Ossenkoppele, R., Tolboom, N., Beunders, A. J. M., Kloet, R. W., Adriaanse, S. M., Boellaard, R., Windhorst, A. D., Raijmakers, P. G. H. M., Adams, H., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.139121 · Cited by 32
Ricci, M., Cimini, A., Chiaravalloti, A., Filippi, L., & Schillaci, O. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207481 · Cited by 33
Efficient Near-Infrared In Vivo Imaging of Amyoid-β Deposits in Alzheimer's Disease Mouse Models
Schmidt, A., & Pahnke, J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112168 · Cited by 31
de Souza, L. C., Lehéricy, S., Dubois, B., Stella, F., & Sarazin, M. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328357b9ab · Cited by 28
Kaskikallio, A., Karrasch, M., Koikkalainen, J., Lötjönen, J., Rinne, J. O., Tuokkola, T., Parkkola, R., & Grönholm-Nyman, P. (2019) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000506124 · Cited by 28
Self-citationAlzheimer disease: From biomarkers to diagnosis
Dubois, B., Epelbaum, S., Santos, A., Stefano, F. D., Julian, A. G., Michon, A., Sarazin, M., & Hampel, H. J. (2013) · Revue Neurologique · doi:10.1016/j.neurol.2013.07.016 · Cited by 34
Ciarmiello, A., Tartaglione, A., Giovannini, E., Riondato, M., Giovacchini, G., Ferrando, O., Biasi, M. D., Passera, C., Carabelli, E., Mannironi, A., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4149-2 · Cited by 28
Amyloid imaging in prodromal Alzheimer's disease
Ossenkoppele, R., van Berckel, B. N. M., & Prins, N. D. (2011) · Alzheimer s Research & Therapy · doi:10.1186/alzrt88 · Cited by 27
Amyloid-β Load Predicts Medial Temporal Lobe Dysfunction in Alzheimer Dementia
Frings, L., Spehl, T. S., Weber, W., Hüll, M., & Meyer, P. T. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.120378 · Cited by 25
Ferreira, L. K., Tamashiro-Duran, J. H., Squarzoni, P., Duran, F., Alves, T. C. T. F., Buchpiguel, C. A., & Busatto, G. F. (2014) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1275 · Cited by 24
Molecular Imaging of Alzheimer Disease Pathology
Kantarci, K. (2014) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3847 · Cited by 24
P ittsburgh compound B retention and progression of cognitive status – a meta‐analysis
Chen, X., Li, M., Wang, S., Zhu, H., Xiong, Y., & Liu, X. (2014) · European Journal of Neurology · doi:10.1111/ene.12398 · Cited by 26
Rinne, J. O., Frantzén, J., Leinonen, V., Lönnrot, K., Laakso, A., Virtanen, K. A., Solin, O. H., Kotkansalo, A., Koivisto, A. M., Sajanti, J., et al. (2013) · Neurodegenerative Diseases · doi:10.1159/000355256 · Cited by 21
Self-citationWarsi, M. A., Molloy, W., & Noseworthy, M. D. (2012) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-012-0312-0 · Cited by 21
Zhu, Y., Initiative, O. B. O. A. D. N., Gong, L., He, C., Wang, Q., Ren, Q., & Xie, C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190254 · Cited by 20
Initiative, A. D. N., Liu, Y.-S., Yan, W., Tan, C., Li, J., Xu, W., Cao, X., Tan, L., & Yu, J. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00105-y · Cited by 21
Cognitive Decline and Amyloid Accumulation in Patients with Mild Cognitive Impairment
Koivunen, J., Karrasch, M., Scheinin, N. M., Aalto, S., Vahlberg, T. J., Någren, K., Helin, S., Viitanen, M. H., & Rinne, J. O. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000341580 · Cited by 22
Self-citationPoinsatte, K., Monson, N. L., Zhang, R., Stowe, A. M., Huebinger, R. M., Cullum, C. M., Monson, N. L., Zhang, R., & Stowe, A. M. (2026) · PubMed · doi:10.22029/eir.2019.1727 · Cited by 18
Added value of amyloid PET in individualized risk predictions for MCI patients
van Maurik, I. S., van der Kall, L. M., de Wilde, A., Bouwman, F. H., Scheltens, P., van Berckel, B. N. M., Berkhof, J. H., van der Flier, W. M., & Initiative, A. D. N. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.04.011 · Cited by 20
Postmortem Pittsburgh Compound B (PiB) Binding Increases with Alzheimer's Disease Progression
Beckett, T. L., Webb, R. L., Niedowicz, D. M., Holler, C. J., Matveev, S., Baig, I., LeVine, H., Keller, J. N., & Murphy, M. P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120655 · Cited by 20
Metadata
- Authors
- Koivunen, J., Scheinin, N., Virta, J. R., Aalto, S., Vahlberg, T., Någren, K., Helin, S., Parkkola, R., Viitanen, M., & Rinne, J. O.
- Affiliations
- University of Turku (FI)
- ORCID
- Venue
- Neurology
- Published
- 2011-03-22
- Volume
- 76
- Issue
- 12
- Pages
- 1085-1090
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2143282099
- Cited by
- 188
- References
- 18
- Citations by year
- 2026: 6 · 2025: 1 · 2024: 4 · 2023: 6 · 2022: 6 · 2021: 11 · 2020: 5 · 2019: 12 · 2018: 9 · 2017: 8 · 2016: 12 · 2015: 12 · 2014: 27 · 2013: 30 · 2012: 32
- FWCI
- 21.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- amnestic mild cognitive impairment, amyloid-beta deposition, Pittsburgh compound B, amyloid PET, hippocampal atrophy, posterior cingulate cortex, temporal cortex, putamen, longitudinal follow-up
- MeSH terms
- Aged, Alzheimer Disease, Aniline Compounds, Atrophy, Brain, Carbon Radioisotopes, Cognition Disorders, Female, Follow-Up Studies, Humans, Male, Neuropsychological Tests, Thiazoles, Amyloid beta-Peptides, Disease Progression, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
